Verastem | VSTM - Fremdkapital





Fremdkapital Veränderung Datum
AbbVie USD 64.53B 5.59B 2026-03
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
AstraZeneca USD 26.01B 46M 2026-06
Curis USD 29.43M 10.69M 2024-06
Cytokinetics USD 248.2M 993K 2026-06
Gilead Sciences USD 20.86B 1.27B 2026-03
Incyte USD 28.42M 994K 2026-06
Laboratory Of America USD 5.92B 23.3M 2026-06
Novartis USD 37.49B 42M 2026-06
Pfizer USD 60.5B 70M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
TG Therapeutics USD 745.39M 247K 2026-06
Verastem USD 76.87M 4.46M 2026-03